Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
about
Long-term outcomes of children after solid organ transplantationPopulation pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant periodPopulation pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients.UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipientsPaediatric use of mycophenolate mofetil.Bile proteome in health and disease.Therapeutic drug monitoring in pediatric renal transplantation.Dosage individualization in children: integration of pharmacometrics in clinical practice.The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.Generic immunosuppressants.Minimum mycophenolic acid levels are associated with donor-specific antibody formation.What is the intrapatient variability of mycophenolic acid trough levels?Developmental changes of MPA exposure in children.Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients.
P2860
Q28660815-A3C245CD-797C-4C15-B820-F4B0D94B0B58Q34570937-4CFE664C-A806-4A78-9074-104E91907966Q36336060-44B55D58-626A-41D9-BFFB-7DC8211CBE4FQ36393014-5BD7565B-B644-4781-9077-DD3CDAA2B26EQ36400272-536E41EC-FDE7-41FF-9E61-1B2D622D4A3AQ36562448-E9DA1C23-70A5-4CD5-BC31-44A25D8C1ACBQ38201380-AABB55C8-C59D-4C53-9B63-3C4BDB45A5A8Q38206952-14352FFB-90A5-4069-9C2C-8D12C96DF4B9Q38240055-1EC8C7F3-D4B1-4D9B-BADA-ACD77C30BF15Q38752528-522D0110-7B6D-4726-BBA8-45A3AC07DAF3Q39451470-7CAEAED3-3EDA-421B-93A8-F27AF8211E84Q40295063-F8208133-A901-46C0-9358-C3B35127DD93Q40707992-E73638EB-99DB-43AA-8423-E8346C227928Q50541249-03DA30D6-8310-4922-8FCA-343EC7940274Q50972464-5E875CF1-B545-41FE-8A59-B601DC0A92A8Q51529212-5AC174BC-EFF3-4701-98E4-EF80F4BE174CQ53163992-857A13DE-632C-46B3-B87B-46C6EB4925E9
P2860
Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric aspects of therapeut ...... acid in renal transplantation.
@en
Pediatric aspects of therapeut ...... acid in renal transplantation.
@nl
type
label
Pediatric aspects of therapeut ...... acid in renal transplantation.
@en
Pediatric aspects of therapeut ...... acid in renal transplantation.
@nl
prefLabel
Pediatric aspects of therapeut ...... acid in renal transplantation.
@en
Pediatric aspects of therapeut ...... acid in renal transplantation.
@nl
P2093
P1476
Pediatric aspects of therapeut ...... acid in renal transplantation.
@en
P2093
Alexander A Vinks
Burkhard Tönshoff
Dirk R J Kuypers
Eileen Tsai
Elias David-Neto
Guido Filler
Jens Goebel
Lothar Bernd Zimmerhackl
Lutz T Weber
Robert Ettenger
P356
10.1016/J.TRRE.2011.01.001
P577
2011-03-30T00:00:00Z